Atara Biotherapeutics
ATRA
ATRA
151 hedge funds and large institutions have $1.24B invested in Atara Biotherapeutics in 2021 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 62 increasing their positions, 42 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.04% less ownership
Funds ownership: 4.18% → 4.15% (-0.04%)
27% less capital invested
Capital invested by funds: $1.7B → $1.24B (-$457M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
151
Holding in Top 10
2
Calls
$1.06M
Puts
$363K
Top Buyers
| 1 | +$20.5M | |
| 2 | +$16.9M | |
| 3 | +$14.4M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.3M |
| 5 |
Renaissance Technologies
New York
|
+$7.26M |
Top Sellers
| 1 | -$26.8M | |
| 2 | -$12M | |
| 3 | -$11.5M | |
| 4 |
BG
Baupost Group
Boston,
Massachusetts
|
-$9.07M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$8.45M |